Sun Pharmaceutical and Taro Pharmaceuticals

Allegations of antitrust violations related to the pricing of certain generic drugs.

This class action settlement resolves claims that Sun Pharmaceutical and Taro Pharmaceuticals engaged in antitrust practices leading to overpayment for certain generic drugs. Eligible individuals and entities in the U.S. (excluding Indiana and Ohio) who purchased, paid for, or were reimbursed for these drugs between May 1, 2009, and Dec. 31, 2019, may be eligible to file a claim.

You may be eligible if you:

• Individuals and entities in the 50 United States (except Indiana and Ohio), District of Columbia, Puerto Rico, and U.S. Virgin Islands.
• Those who indirectly purchased, paid for, or provided reimbursement for named generic drugs.
• Purchases made between May 1, 2009, and Dec. 31, 2019, not for resale.

• Basic contact information
• Purchases made between May 1, 2009, and Dec. 31, 2019.
• Proof of purchase or supporting documents

If you do not have every document, you may still be able to file. Many settlements accept claims without receipts.

• Visit the official settlement website and click to file a claim.
• Download and review the list of named generic drugs.
• Complete and submit the claim form with supporting documentation.
• Ensure you are submitting the claim under penalty of perjury.